173 related articles for article (PubMed ID: 17302279)
1. [Molecular imaging in Parkinson's disease].
Arahata Y; Kato T; Ito K
Nihon Rinsho; 2007 Feb; 65(2):327-31. PubMed ID: 17302279
[TBL] [Abstract][Full Text] [Related]
2. PET and SPECT functional imaging studies in Parkinsonian syndromes: from the lesion to its consequences.
Thobois S; Jahanshahi M; Pinto S; Frackowiak R; Limousin-Dowsey P
Neuroimage; 2004 Sep; 23(1):1-16. PubMed ID: 15325346
[TBL] [Abstract][Full Text] [Related]
3. Molecular Imaging of the Dopaminergic System in Idiopathic Parkinson's Disease.
de Natale ER; Niccolini F; Wilson H; Politis M
Int Rev Neurobiol; 2018; 141():131-172. PubMed ID: 30314595
[TBL] [Abstract][Full Text] [Related]
4. SPECT imaging of the dopaminergic system in (premotor) Parkinson's disease.
Booij J; Knol RJ
Parkinsonism Relat Disord; 2007; 13 Suppl 3():S425-8. PubMed ID: 18267276
[TBL] [Abstract][Full Text] [Related]
5. Imaging beyond the striatonigral dopaminergic system in Parkinson's disease.
Giza E; Gotzamani-Psarrakou A; Bostantjopoulou S
Hell J Nucl Med; 2012; 15(3):224-32. PubMed ID: 23106055
[TBL] [Abstract][Full Text] [Related]
6. Optimizing diagnosis in Parkinson's disease: Radionuclide imaging.
Arena JE; Stoessl AJ
Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1():S47-51. PubMed ID: 26439947
[TBL] [Abstract][Full Text] [Related]
7. Imaging the nigrostriatal system to monitor disease progression and treatment-induced complications.
Kuriakose R; Stoessl AJ
Prog Brain Res; 2010; 184():177-92. PubMed ID: 20887875
[TBL] [Abstract][Full Text] [Related]
8. Imaging neurodegeneration in Parkinson's disease.
Pavese N; Brooks DJ
Biochim Biophys Acta; 2009 Jul; 1792(7):722-9. PubMed ID: 18992326
[TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter density measured by [123I]beta-CIT single-photon emission computed tomography is normal in dopa-responsive dystonia.
Jeon BS; Jeong JM; Park SS; Kim JM; Chang YS; Song HC; Kim KM; Yoon KY; Lee MC; Lee SB
Ann Neurol; 1998 Jun; 43(6):792-800. PubMed ID: 9629849
[TBL] [Abstract][Full Text] [Related]
10. Neuroprotection and imaging studies in Parkinson's disease.
Pavese N; Kiferle L; Piccini P
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S33-7. PubMed ID: 20123554
[TBL] [Abstract][Full Text] [Related]
11. Radiotracers for imaging of Parkinson's disease.
Abbasi Gharibkandi N; Hosseinimehr SJ
Eur J Med Chem; 2019 Mar; 166():75-89. PubMed ID: 30685535
[TBL] [Abstract][Full Text] [Related]
12. Functional imaging in pre-motor Parkinson's disease.
Arnaldi D; Morbelli S; Picco A; Ferrara M; Buschiazzo A; Famà F; De Carli F; Nobili F
Q J Nucl Med Mol Imaging; 2014 Dec; 58(4):366-75. PubMed ID: 25366709
[TBL] [Abstract][Full Text] [Related]
13. Crossover study of (99m)Tc-TRODAT-1 SPECT and (18)F-FDOPA PET in Parkinson's disease patients.
Huang WS; Chiang YH; Lin JC; Chou YH; Cheng CY; Liu RS
J Nucl Med; 2003 Jul; 44(7):999-1005. PubMed ID: 12843212
[TBL] [Abstract][Full Text] [Related]
14. Dopaminergic function and progression of Parkinson's disease: PET findings.
Biju G; de la Fuente-Fernández R
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 4():S38-40. PubMed ID: 20123555
[TBL] [Abstract][Full Text] [Related]
15. Long-term changes of striatal dopamine D2 receptors in patients with Parkinson's disease: a study with positron emission tomography and [11C]raclopride.
Antonini A; Schwarz J; Oertel WH; Pogarell O; Leenders KL
Mov Disord; 1997 Jan; 12(1):33-8. PubMed ID: 8990051
[TBL] [Abstract][Full Text] [Related]
16. PET and SPECT studies in Parkinson's disease.
Brooks DJ
Baillieres Clin Neurol; 1997 Apr; 6(1):69-87. PubMed ID: 9426869
[TBL] [Abstract][Full Text] [Related]
17. The meaning of negative DAT SPECT and F-Dopa PET scans in patients with clinical Parkinson's disease.
Morrish P
Mov Disord; 2005 Jan; 20(1):117; author reply 117-8. PubMed ID: 15468100
[No Abstract] [Full Text] [Related]
18. Functional imaging studies of non-motoric manifestations of Parkinson's Disease.
Stoessl AJ
Parkinsonism Relat Disord; 2009 Dec; 15 Suppl 3():S13-6. PubMed ID: 20082973
[TBL] [Abstract][Full Text] [Related]
19. Imaging the Nonmotor Symptoms in Parkinson's Disease.
Yousaf T; Wilson H; Politis M
Int Rev Neurobiol; 2017; 133():179-257. PubMed ID: 28802921
[TBL] [Abstract][Full Text] [Related]
20. Quantitative [(123)I]FP-CIT pinhole SPECT imaging predicts striatal dopamine levels, but not number of nigral neurons in different mouse models of Parkinson's disease.
Alvarez-Fischer D; Blessmann G; Trosowski C; Béhé M; Schurrat T; Hartmann A; Behr TM; Oertel WH; Höglinger GU; Höffken H
Neuroimage; 2007 Oct; 38(1):5-12. PubMed ID: 17716921
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
